ASBMR Webinar: Bench to Bedside and Back Again: Romozosumab: Clinical Applications with Fracture Outcomes and Sclerostin Biology

Bench to Bedside and Back Again: Romozosumab: Clinical Applications with Fracture Outcomes and Sclerostin Biology

Basic perspective: Gaby Loots, Ph.D., University of California at Merced

Clinical perspective: Kenneth Saag, M.D., University of Alabama at Birmingham

Register for this Webinar Here